Stay updated on VRDN 001 Safety and Efficacy in TED Clinical Trial
Sign up to get notified when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.

Latest updates to the VRDN 001 Safety and Efficacy in TED Clinical Trial page
- CheckyesterdayChange DetectedThe clinical-trial record for the completed veligrotug study in thyroid eye disease is available, with study design, eligibility criteria, participating locations, and outcome measures. Study documents and record dates are also provided.SummaryDifference71%

- Check8 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check22 days agoChange DetectedThe displayed site revision was updated from v3.7.1 to v3.7.2 on an otherwise unchanged 403 Forbidden page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0; the page remains a 403 error screen.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with a minimal error screen and navigation, indicating the page is inaccessible.SummaryDifference0.5%

Stay in the know with updates to VRDN 001 Safety and Efficacy in TED Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.